Citigroup downgrades Edwards Lifesciences Corp (NYSE: EW) from Hold to Sell. Price target lowered from $49 to $44.

This article: 102 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE